Please login to the form below

clinical benefit

This page shows the latest clinical benefit news and features for those working in and with pharma, biotech and healthcare.

Biogen and Eisai claim mid-stage win for Alzheimer’s drug

They estimate– based on Eisai’s earlier communications on the drug and trial design – that the clinical benefit could be around 20-25% and “certainly very clinically meaningful”if so.

Latest news

ICER says price of Amgen/Novartis’ Aimovig is OK - if used last-line

Novartis and Amgen’s decision to price their new migraine drug Aimovig lower than expected seems to have paid off, with US pricing watchdog ICER concluding that it matches the clinical ... ICER (the Institute for Clinical and Economic Review) estimates
Safety scuppers combo trials with J&J/Genmab’s Darzalex

There was a “numerical increase”in deaths when Darzalex was added to Tecentriq and no evidence of any increase in clinical benefit compared to Tecentriq on its own in the LUC2001 ... We are pleased that the development program for daratumumab remains
Daily Brief

The company has a second drug, cancer candidate Clevegen, a novel anti-Clever-1 antibody, which enters clinical trials later this year. ... They say the algorithm takes into account the actual costs of R&D, manufacturing, sales, marketing and a fair
Another IO knockback as Tecentriq combo fails phase III trial

cancer (CRC) showed no benefit on overall survival compared to Bayer’s Stivarga (regorafenib), a drug typically used in that hard-to-treat population. ... The results from IMblaze370 were consistent with this prior monotherapy experience, showing that
New industry standards group launched

New industry standards group launched. Align Clinical CRO will improve clinical trial collaboration. ... Henry Levy, president of Align Clinical CRO, said: “There’s tremendous potential to enhance clinical trial execution through common technology

More from news
Approximately 1 fully matching, plus 152 partially matching documents found.

Latest Intelligence

Can new data aggregators shift the balance of power away from pharma?

This could have far-reaching consequences for some players in the pharmaceutical industry who may find their product pricing to be untenable when the cost/clinical benefit calculus becomes totally transparent.
Patient recruitment and engagement standards

And the reality: 50% of clinical research sites don’t recruit a single patient. ... A number of studies have revealed that awareness changes patients’perceptions about clinical trials, enrolment and the risk/benefit ratio of getting involved.
Taking a lean and careful approach

Chemotherapy and Pharmacology, which concluded its treatment regimen showed ‘encouraging clinical benefit’. ... Clinical trials. The company is moving cautiously and set its clinical trials in Israel, Italy, Turkey and Greece.
Strengthening market access deliverables by harnessing the patient journey

Topics such as the clinical value of new products, or what impact the product has on outcomes are relevant to multiple stakeholders. ... management, clinical benefit and economic/humanistic benefit.
The value of early asset development and commercialisation

Linking the clinical benefit of a product to a real-world benefit that markets care about, insurers will pay for and that will improve patients’ lives is critical for pipeline assets ... It will follow the asset development journey, defining value from

More from intelligence
Approximately 0 fully matching, plus 22 partially matching documents found.

Latest appointments

Dr Irina Antonijevic joins vasopharm

In this role, Dr Antonijevic will be responsible for advancing the clinical development of the cerebrovascular specialist's lead orphan drug candidate, VAS203. ... Not only will we benefit from her clinical capabilities in our ongoing pivotal study of
ICON's CEO named chair of ACRO

ICON's CEO named chair of ACRO. Trade body for clinical research organisation elects Ciaran Murray. ... I look forward to continuing the work that ACRO has done in promoting our industry as one that conducts safe, ethical and high-quality clinical
Industry veteran Louis Nisbet joins Sygnature board

The UK-based clinical research organisation (CRO) will benefit from Dr Nisbet's extensive experience in the life sciences industry, which includes spells in research at Roche, Glaxo and SmithKline.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

Why and how doctors should be involved in startups

provide useful clinical insight that can benefit a startup.
Immunotherapy in oncology

These three states align with the clinical observations of response, stable disease and progression of disease. ... However, the group recognised that delayed responses and prolonged stable disease were having a significant survival benefit, underscoring
What will the NHS’s Capped Expenditure Process (CEP) mean for pharma?

Balancing doctors’ demands for drugs that demonstrate strong clinical benefit and patient safety against medicines management teams’ focus on cost savings will be critical in CEP areas. ... In such areas, bringing together multi-disciplinary networks
How will the NHS’s new medicines savings drive affect pharma?

Engagement tactics must balance clinicians’ demand for products that show strong clinical benefit and patient safety against medicines management teams’ focus on the cost savings that can be generated by specific ... full benefit of expensive drugs,
The Heart of the Matter 7: Reality Dawns

In tandem, as the limitations of the 'gold standard' randomised clinical trial (RCT) data are increasingly exposed, European initiatives such as the Innovative Medicines Initiative GetReal and ADAPT-SMART underline how ... The Centre has four areas of